Aker Biomarine AS Total Liabilities
Aker Biomarine AS total liabilities. Based on the latest financial reports, Aker Biomarine AS (AKBM) has total liabilities worth Nkr237.50 Million NOK (≈ $24.99 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check AKBM asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Aker Biomarine AS (2016–2024)
Total liabilities of Aker Biomarine AS from 2016 to 2024. This chart illustrates how Aker Biomarine AS's total liabilities have evolved over time, based on quarterly financial data.
Aker Biomarine AS Competitors by Total Liabilities
The table below lists competitors of Aker Biomarine AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
U-Haul Holding Company
NYSE:UHAL
|
USA | $13.87 Billion |
|
Shenzhen Jufei Optoelectronics
SHE:300303
|
China | CN¥2.53 Billion |
|
UTI Asset Management Company Limited
NSE:UTIAMC
|
India | Rs-45.05 Billion |
|
TMC the metals company Inc
NASDAQ:TMC
|
USA | $215.07 Million |
|
MannKind Corp
NASDAQ:MNKD
|
USA | $799.50 Million |
|
Certara Inc
NASDAQ:CERT
|
USA | $493.79 Million |
|
Cymbria Corporation
TO:CYB
|
Canada | CA$138.94 Million |
|
PROS Holdings Inc
NYSE:PRO
|
USA | $521.11 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Aker Biomarine AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Aker Biomarine AS (AKBM) total assets.
Liquidity & Leverage Metrics
Aker Biomarine AS Total Liabilities Ratios Explained
Aker Biomarine AS total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.26 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.59 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aker Biomarine AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aker Biomarine AS (2016–2024)
The table below shows the annual total liabilities of Aker Biomarine AS from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr213.50 Million ≈ $22.47 Million |
-53.65% |
| 2023-12-31 | Nkr460.60 Million ≈ $48.47 Million |
+3.32% |
| 2022-12-31 | Nkr445.80 Million ≈ $46.91 Million |
+15.16% |
| 2021-12-31 | Nkr387.12 Million ≈ $40.74 Million |
+18.29% |
| 2020-12-31 | Nkr327.26 Million ≈ $34.44 Million |
-39.13% |
| 2019-12-31 | Nkr537.68 Million ≈ $56.58 Million |
+113.84% |
| 2018-12-31 | Nkr251.43 Million ≈ $26.46 Million |
-20.96% |
| 2017-12-31 | Nkr318.12 Million ≈ $33.47 Million |
+54.94% |
| 2016-12-31 | Nkr205.32 Million ≈ $21.61 Million |
-- |
About Aker Biomarine AS
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LY… Read more